Clinical Trials Directory

Trials / Completed

CompletedNCT00682045

Latent Tuberculosis Infection in Renal Transplant Recipients

A Prospective Observational Study of Usefulness of a T Cell-based Assay for Latent Tuberculosis Infection in Renal Transplant Recipients

Status
Completed
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to estimate the usefulness of a T cell-based assay (i.e. T-SPOT.TB assay) for diagnosis of latent tuberculosis infection (LTBI) in renal transplant recipients. For this purpose, the investigators enrolled renal transplant recipients and observed the developement of tuberculosis within 1 to 2 years after the transplantation.

Detailed description

We evaluate the usefulness of a newly-developed T cell-based assay prior to undergoing immunosuppression in renal transplant recipients. Among all renal transplant recipients, patients with negative tuberculin skin test and no other indications for latent tuberculosis infection will be enrolled in this study. We will exam T-SPOT.TB test in these patients, and observe the developement of tuberculosis within 1 to 2 years after the transplantation. The results of T-SPOT.TB will be blinded to the investigators.

Conditions

Timeline

Start date
2008-06-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2008-05-21
Last updated
2010-06-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00682045. Inclusion in this directory is not an endorsement.